The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...

Press releaseGenethon and Eukarÿs announce a strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...

New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid ...

X-linked sideroblastic anemia (XLSA) is a rare genetic disorder caused by mutations in the ALAS2 gene, which plays a critical role in heme biosynthesis within red blood cells.

Individual cells in the brain light up for specific ideas. These concept neurons, once known as “Jennifer Aniston cells,” ...

A recent study reveals a sharp rise in neuroinvasive Toscana virus infections in Italy from 2022 to 2023, driven by climate ...

By Dr. Chinta Sidharthan Scientists have unveiled a novel mosquito control strategy: genetically engineered fungi that spread ...

A landmark study from the University of Illinois, published in Agronomy Journal, highlights the transformative potential of Pivot Bio's patented gene-edited microbes as an essential third source of ...

The integration enables closed system processing, a significant step in automating platforms and protocols for cell therapies ...